Guidelines for implantation of defibrillators;Leitlinien zur implantation von defibrillatoren

Clinical Research in Cardiology

Volumn 95, Issue 12, 2006, Pages 696-708

  Jung, Werner ^a   Andresen, Dietrich ^b   Block, Michael ^c   Böcker, Dirk ^d   Hohnloser, Stefan H ^e   Kuck, Karl Heinz ^f   Sperzel, Johannes ^g  

^a SCHWARZWALD BAAR KLINIKUM   (Germany)

^b VIVANTES KLINIKUM AM URBAN   (Germany)

^c Klinik Augustinum Munchen   (Germany)

^d UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^e GOETHE UNIVERSITY   (Germany)

^f DEPARTMENT OF CARDIOLOGY   (Germany)

^g KERCKHOFF HEART CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AJMALINE; AMIODARONE; ANTIARRHYTHMIC AGENT; FLECAINIDE; PLACEBO;

DEFIBRILLATION; DEFIBRILLATOR; EVIDENCE BASED PRACTICE; HEART ARRHYTHMIA; HEART HEMODYNAMICS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMPLANTATION; LONG QT SYNDROME; REVIEW; TACHYCARDIA;

DEFIBRILLATORS, IMPLANTABLE; EVIDENCE-BASED MEDICINE; GERMANY; HUMANS; PRACTICE GUIDELINES; SOCIETIES, MEDICAL;

EID: 33845356557     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-006-0475-7     Document Type: Review

References (45)

1. Al-Khatib SM, Lucas FE, Jollis JG, Malenka DJ, Wennberg DE (2005) The relation between patients' outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating medicare beneficiaries. J Am Coll Cardiol 46:1536-1540
2. Andrews NP, Fogel RI, Pelargonio G, Evans JJ, Prystowsky EN (1999) Implantable defibrillator event rates in patients with unexplained syncope and inducible sustained ventricular tachyarrhythmias: a comparison with patients known to have sustained ventricular tachycardia. J Am Coll Cardiol 34:2023-2030
3. Antzelevitch C, Brugada P, Borggrefe M et al (2005) Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 111:659-670 (Erratum in: Circulation 2005;112(4):e74)
4. Bänsch D, Brunn J, Castrucci M et al (1998) Syncope in patients with an implantable cardioverter-defibrillator: incidence, prediction and implications for driving restrictions. J Am Coll Cardiol 31:608-615
5. Bänsch D, Antz M, Boczor S et al (2002) Primary Prevention of Sudden Cardiac Death in Idiopathic Dilated Cardiomyopathy: The Cardiomyopathy Trial (CAT). Circulation 105:1453-1458
6. Bardy GH, Lee KL, Mark DB et al (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225-237
7. Böcker D, Block M, Isbruch F et al (1995) Benefits of treatment with implantable cardioverter-defibrillators in patients with stable ventricular tachycardia without cardiac arrest. Br Heart J 73:158-163
8. Brilakis ES, Shen WK, Hammill SC, Hodge DO, Rea RF, Lexvold NY, Friedman PA (2001) Role of programmed ventricular stimulation and implantable cardioverter defibrillators in patients with idiopathic dilated cardiomyopathy and syncope. Pacing Clin Electrophysiol 24:1623-1630
9. Bristow MR, Saxon LS, Boehmer J et al (2004) Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350:2140-2150
10. Coggins DL, Lee RJ, Sweeney J et al (1994) Radiofrequency catheter ablation as a cure for idiopathic tachycardia of both left and right ventricular origin. J Am Coll Cardiol 23:1333-1341
11. Connolly SJ, Gent M, Roberts RS et al (1993) Canadian Implantable Defibrillator Study (CIDS): Study design and organization. Am J Cardiol 72:103F-108F
12. Connolly SJ, Gent M, Roberts RS et al (2000) Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 101:1297-1302
13. Connolly SJ, Hallstrom AP, Cappato R et al (2000) Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J 21:2071-2078
14. Cook JR, Rizo-Patron C, Curtis AB et al (2002) Effect of surgical revascularization in patients with coronary artery disease and ventricular tachycardia or fibrillation in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Registry. Am Heart J 143:821-826
15. Corrado D, Leoni L, Link MS et al (2003) Implantable cardioverter- defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 108:3084-3091
16. Domanski MJ, Sakseena S, Epstein AE et al (1999) Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. AVID Investigators. Antiarrhythmics Versus Implantable Defibrillators. J Am Coll Cardiol 34:1090-1095
17. Groh WJ, Silka MJ, Oliver RP, Halperin BD, McAnulty JH, Kron J (1996) Use of implantable cardioverter-defibrillators in the congenital long QT syndrome. Am J Cardiol 78:703-706
18. Hohnloser SH, Andresen D, Block M et al (2000) Leitlinien zur Implantation von Defibrillatoren. Z Kardiol 89:126-135
19. Hohnloser SH, Kuck KH, Dorian P et al (2004) Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 351:2481-2488
20. Jung W, Lüderitz B (1996) Quality of life and driving in recipients of the implantable cardioverter-defibrillator. Am J Cardiol 78:51-56
21. Jung W, Anderson M, Camm AJ et al (1997) Recommendations for driving of patients with implantable cardioverter defibrillators. Eur Heart J 18:1210-1219
22. Kadish A, Dyer A, Daubert JP et al (2004) Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350:2151-2158
23. Knight BP, Goyal R, Pelosi F, Flemming M, Horwood L, Morady F, Strickberger SA (1999) Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. J Am Coll Cardiol 33:1964-1970
24. Kuck KH, Cappato R, Siebels J, Ruppel R (2000) Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 102:748-754
25. Mangi AA, Boeve TJ, Vlahakes GJ et al (2002) Surgical coronary revascularization and antiarrhythmic therapy in survivors of out-of-hospital cardiac arrest. Ann Thorac Surg 74:1510-1516
26. Maron BJ, Shen WK, Link MS et al (2000) Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 342:365-373
27. Maron BJ, McKenna WJ, Danielson GK et al (2003) American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J 24:1965-1991
28. Mittal S, Iwai S, Stein KM, Markowitz SM, Slotwiner DJ, Lerman BB (1999) Long-term outcome of patients with unexplained syncope treated with an electrophysiologic-guided approach in the implantable cardioverter-defibrillator era. J Am Coll Cardiol 34:1082-1089
29. Mittal S, Hao SC, Iwai S, Markowitz SM, Slotwiner DJ, Lerman BB (2001) Significance of inducible ventricular fibrillation in patients with coronary artery disease and unexplained syncope. J Am Coll Cardiol 38:371-376
30. Moss AJ, Zarebra W, Hall WJ et al (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877-883
31. Nademanee K, Veerakul G, Mower M et al (2003) Defibrillator Versus beta-Blockers for Unexplained Death in Thailand (DEBUT): a randomized clinical trial. Circulation 107:2221-2226
32. Olson PJ, Woelfel A, Simpson RJ Jr, Foster JR (1993) Stratification of sudden death risk in patients receiving long-term amiodarone treatment for sustained ventricular tachycardia or ventricular fibrillation. Am J Cardiol 71:823-826
33. Priori SG, Schwartz PJ, Napolitano C et al (2003) Risk stratification in the long-QT syndrome. N Engl J Med 348:1866-1874
34. Raitt MH, Renfroe EG, Epstein AE et al (2001) "Stable" ventricular tachycardia is not a benign rhythm: insights from the antiarrhythmics versus implantable defibrillators (AVID) registry. Circulation 103:244-252
35. Salukhe TV, Dimopoulos K, Sutton R, Coats AJ, Piepoli M, Francis DP (2004) Life-years gained from defibrillator implantation: markedly nonlinear increase during 3 years of follow-up and its implications. Circulation 109:1848-1853
36. Schimpf R, Bauersfeld U, Gaita F, Wolpert C (2005) Short QT syndrome: successful prevention of sudden cardiac death in an adolescent by implantable cardioverter-defibrillator treatment for primary prophylaxis. Heart Rhythm 2:416-417
37. Sheldon R, Connolly S, Krahn A, Roberts R, Gent M, Gardner M (2000) Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy: the Canadian Implantable Defibrillator Study. Circulation 101:1660-1664
38. Siebels J, Kuck KH (1994) Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg). Am Heart J 127:1139-1144
39. Steinberg JS, Beckman K, Greene HL et al (2001) Follow-up of patients with unexplained syncope and inducible ventricular tachyarrhythmias: analysis of the AVID registry and an AVID substudy. Antiarrhythmics Versus Implantable Defibrillators. J Cardiovasc Electrophysiol 12:996-1001
40. Strickberger SA, Hummel JD, Bartlett TG et al (2003) Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia - AMIOVIRT. J Am Coll Cardiol 41:1707-1712
41. The AVID Investigators (1995) Antiarrhythmics Versus Implantable Defibrillators (AVID) - rationale, design, and methods. Am J Cardiol 75:470-475
42. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators (1997) A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmias. N Engl J Med 337:1576-1583
43. Wichter T, Paul M, Wollmann C et al (2004) Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients. Circulation 109:1503-1508
44. Wilber DJ, Zareba W, Hall WJ et al (2004) Time dependence of mortality risk and defibrillator benefit after myocardial infarction. Circulation 109:1082-1084
45. Zareba W, Moss AJ, Daubert JP, Hall WJ, Robinson JL, Andrews M (2003) Implantable cardioverter defibrillator in high-risk long QT syndrome patients. J Cardiovasc Electrophysiol 14:337-341